
Grindr Stock Falls 8% After $250M PurposeMed Deal
Why did Grindr stock fall 8%?
Grindr (GRND) stock fell 8.2% to $14.17 on Thursday after it announced a $250 million cash-and-stock deal for PurposeMed, a price investors weighed against its cash cost and dilution.
Key numbers
| Deal value | $250M$190M cash + $60M stock |
|---|---|
| GRND close (Oct 1) | $14.17-8.17%; outlets cite -7.9% to -8.8% intraday |
| Possible earnout | Up to $70Mcash, payable 2028 |
| Freddie 2026 revenue | >$80Mcompany expectation |
| Freddie 2026 adj. EBITDA | >$10Mcompany expectation |
What happened
Grindr (GRND) stock fell 8.2% to $14.17 on Thursday after it announced a $250 million cash-and-stock deal for PurposeMed, a price investors weighed against its cash cost and dilution. Grindr will pay $190 million in cash and $60 million in shares, and could owe up to $70 million more in 2028 if PurposeMed hits its 2027 goals. PurposeMed owns Freddie, an online clinic for HIV-prevention medicine (PrEP), and expects over $80 million in 2026 sales and over $10 million in adjusted profit (EBITDA). The deal is expected to close in the fourth quarter.
Why it matters
Grindr is moving beyond its dating app into healthcare, with what Yahoo Finance calls its first major acquisition since it was founded in 2009. Paying $190 million in cash and issuing new shares can shrink what each existing share is worth (dilution), and some investors doubt the extra payment targets will be met. Grindr said the deal will barely change 2026 results, with 2027 details due at its November earnings call.
Who this affects
- MarketbearishLow impact
- Investors sold Grindr shares; bad for current holders.
- CompanybearishMedium impact
- Cash spend and new shares weigh on Grindr shareholders.
- CompetitorsneutralLow impact
- Match Group and Bumble barely moved; little direct effect.
- IndustrymixedLow impact
- Shows dating apps pushing into health services.
Grindr vs Match Group, Bumble, Hims & Hers
How we got here
Grindr announces agreement to buy PurposeMed, parent of telehealth provider Freddie
Grindr shares close at $14.17, down 8.17%, as investors react to the deal
What to watch
- Grindr's third-quarter earnings call, where it plans to detail its 2027 outlook including Freddie2026-11
- Deal closing, which Grindr expects after closing conditions are metQ4 2026
- Whether Freddie meets 2027 targets that trigger the up-to-$70M cash earnout2028
Educational content only. Not investment advice.
More briefsAll briefs →

Tesla Stock Falls 22% This Year as Q3 Deliveries Near
Tesla (TSLA) is expected to deliver about 462,000 cars in Q3, down 7%, as US and China demand weakens.
Vicor Stock Jumps 6.8% After Guidance Raise
Vicor (VICR) lifted its Q3 growth outlook to over 30% from 20% on royalties from its first power-tech license.

United Therapeutics Stock Jumps 12.5% After Patent Win
United Therapeutics (UTHR) beat Liquidia in a patent case; BTIG upgraded it to Buy with a $728 target.